financetom
Business
financetom
/
Business
/
Update: Goldman Sachs CEO Expects Upswing in M&A Activity in 2026 Despite Middle East Conflict
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Update: Goldman Sachs CEO Expects Upswing in M&A Activity in 2026 Despite Middle East Conflict
Mar 20, 2026 6:19 AM

08:52 AM EDT, 03/20/2026 (MT Newswires) -- (Updates with medium-term return targets for asset and wealth division in fifth paragraph.)

Goldman Sachs Group ( GS ) expects an upswing in mergers and acquisitions activity this year despite the impact of the Middle East conflict, Chief Executive David Solomon said Friday in an annual letter to shareholders.

Goldman sees "the potential for a more constructive operating environment," based on factors such as fiscal stimulus in developed economies, monetary easing, AI capital investment, and a more balanced regulatory regime in the US, Solomon said in the letter.

Goldman also expects strategic transactions to accelerate this year as the regulatory change causes boards and CEOS to adopt a "much more front-footed approach" to executing strategic deals.

"We expect this upswing to continue -- though a protracted war or another exogenous event could, of course, change the current sentiment," Solomon said.

Goldman's Asset & Wealth Management division is targeting returns of 17% to 19% over the next three to five years. "While the bar for M&A remains very high, we will continue to look for ways to accelerate growth in AWM," Solomon said.

The executive also highlighted the importance of the US-China relationship. "Given how entwined they are, it is important that the US and China reach a new modus vivendi, not just for the next 12 months, but rather for the next 10 to 20 years," he said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
DigitalOcean's Q3 Non-GAAP Earnings, Revenue Rise; Issues Q4 Outlook
DigitalOcean's Q3 Non-GAAP Earnings, Revenue Rise; Issues Q4 Outlook
Nov 4, 2024
08:00 AM EST, 11/04/2024 (MT Newswires) -- DigitalOcean Holdings ( DOCN ) reported Q3 non-GAAP earnings Monday of $0.52 per diluted share, up from $0.44 a year earlier. Analysts polled by Capital IQ expected $0.40. Revenue for the quarter ended Sept. 30 was $198.5 million, compared with $177.1 million a year earlier. Analysts polled by Capital IQ expected $196.8 million....
Frontdoor's Q3 Adjusted Earnings, Revenue Rise; 2024 Revenue Outlook Revised
Frontdoor's Q3 Adjusted Earnings, Revenue Rise; 2024 Revenue Outlook Revised
Nov 4, 2024
08:27 AM EST, 11/04/2024 (MT Newswires) -- Frontdoor ( FTDR ) reported Q3 adjusted earnings Monday of $1.38 per diluted share, up from $0.94 a year earlier. Analysts polled by Capital IQ expected $1.05. Revenue for the quarter ended Sept. 30 was $540 million, up from $524 million a year earlier. Analysts surveyed by Capital IQ expected $541.9 million. For...
Entree Resources Reports Additional Drill Results from 2023 Program at Hugo North Extension in Mongolia
Entree Resources Reports Additional Drill Results from 2023 Program at Hugo North Extension in Mongolia
Nov 4, 2024
08:29 AM EST, 11/04/2024 (MT Newswires) -- Entree Resources ( ERLFF ) reported Monday additional drill results from its 2023 drilling program over the Hugo North Extension deposit on the Entree/Oyu Tolgoi joint venture property in Mongolia. Highlights include 448 meters grading 1.62% copper equivalent, including 172 meters grading 1.99% copper equivalent. Hugo North, including the Hugo North Extension deposit...
DRI Healthcare Trust Acquires Royalty Stake in Global Sales of Sebetralstat
DRI Healthcare Trust Acquires Royalty Stake in Global Sales of Sebetralstat
Nov 4, 2024
08:28 AM EST, 11/04/2024 (MT Newswires) -- DRI Healthcare Trust (DHT-UN.TO, DHT-U.TO) said Monday it has acquired a royalty interest in the global net sales of all formulations of sebetralstat from KalVista Pharmaceuticals, for up to US$179 million. The payment consists of a US$100 million upfront payment, up to US$57 million in a sales-based milestone payment and a one-time US$22...
Copyright 2023-2026 - www.financetom.com All Rights Reserved